BIVI
BIOVIE INC.
Key Financials
Net Income
$-17542120
↑ 45.4%
Revenue
$0
N/A
Operating Income
$-18066200
↑ 43.9%
EPS (Diluted)
$-12.12
↓ 66.0%
Cash & Equivalents
$17.5M
↓ 26.4%
Total Assets
$21.6M
↓ 14.5%
Shareholders' Equity
$19.0M
↑ 22.6%
Total Liabilities
$2.6M
↓ 73.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| EFFECT | 6/29/2026 | View on SEC |
| S-3 | 6/18/2026 | View on SEC |
| 10-Q | 5/11/2026 | View on SEC |
| SCHEDULE 13D | 3/25/2026 | View on SEC |
| 10-Q | 2/6/2026 | View on SEC |
| 4 | 1/9/2026 | View on SEC |
| 4 | 1/9/2026 | View on SEC |
| 4 | 1/9/2026 | View on SEC |
| 4 | 1/9/2026 | View on SEC |
| 4 | 1/9/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BIVI |
| Company Name | BIOVIE INC. |
| CIK | 1580149 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | NV |
| Phone | 775-888-3162 |